co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Aequs share price: This comes after the Rs 922-crore IPO was subscribed nearly 102 times from December 3-5.
Meesho share market debut was better than the expectations in the grey market, which had expected a listing gain of about 39 percent.
India’s IPO pipeline is swelling rapidly, with 88 companies already securing SEBI approval to raise Rs 1.16 lakh crore and another 104 awaiting clearance for nearly Rs 1.4 lakh crore
Two of the country’s prominent investment banks — Arif Habib Ltd. and Ktrade Securities Ltd. — have a combined pipeline of as many as 16 IPOs over the next seven months
The Rs 922-crore IPO had attracted strong investor demand, getting subscribed nearly 102 times during the bidding window from December 3 to 5.
InCred has given the stock a Subscribe rating for near-term gains, citing attractive valuations at 5.3x market cap-to-sales.
Park Medi World IPO | The Rs 920-crore initial public offering will open during December 10-12, with price band of Rs 154-162 per share.
The Nephrocare Health Services IPO is a combination of fresh issuance of shares worth Rs 353.4 crore, and an offer-for-sale of 1.12 crore shares by existing shareholders.
KSH International IPO | The stake sale has done at a price of Rs 384 per share, valuing the company at little more than Rs 2,600 crore.
Steamhouse India IPO | The company proposed to mobilise Rs 345 crore by issuing fresh shares, while promoter Vishal Sanwarprasad Budhia will offload shares worth up to Rs 80 crore via offer-for-sale.
The analysts advised investors to hold the Vidya Wires shares for the medium to long term.
Analysts expect the Meesho shares to list at a 25–30 percent premium and advise a cautious approach thereafter, depending on investor risk appetite.
The SEBI had put the issuance of observations on Sterlite Electric’s IPO papers in abeyance on October 27.
Aequs listing expectations: Analysts advised investors to book partial profits on listing gains and holding the rest for long term.
The capital markets regulator has issued observations on the draft document of Molbio Diagnostics on December 1, followed by Leap India, and Eldorado Agritech on December 5
The home-solutions brand plans faster furniture-led growth and a major Tier-2 retail rollout as its Rs 1,289-crore IPO opens for public subscription.
The Bengaluru-based company has held preliminary discussions with bankers about a potential listing
Wakefit IPO share allotment is expected by December 11, while the shares are proposed to be listed on December 15.
Corona Remedies IPO: The price band for the IPO has been set at Rs 1,008-1,062 per share.
Deven Choksey, has come out with its report on Wakefit Innovations Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 08, 2025.
Helloji Holidays share price: The Rs 11-crore IPO saw strong investor interest during its three days of public bidding, being subscribed more than 27 times from December 2-4.
Shares of Meesho, Aequs and Vidya Wires are showing a firm trend in the grey market, with premiums of about 35 percent.
Both companies will finalise their IPO share allotment by December 9, while their shares will be available for trading on the BSE SME effective December 11.
Nephrocare Health Services IPO | The company approached capital markets to raise Rs 871 crore via initial public offering (IPO) comprising fresh issuance of shares worth Rs 353.4 crore.
The proceeds surpassed last year’s high of Rs 1.73 lakh crore, according to data compiled by Bloomberg
